The startup, Veraxa, has $253 million in cash and is raising a crossover funding round to support a pipeline of T cell ...

Drugmaker Merck reports quarterly results Thursday morning as fears grow over the expiration of the patent on its top-selling ...

Merck & Co reports Q1 earnings on Thursday with EPS of $2.14 and revenue of $15.33B expected. Despite a 38.04% drop in stock ...

In the last two years, Merck has beaten EPS estimates 88% of the time, and revenue estimates 100% of the time. Meanwhile, ...

Jiangsu Hengrui Pharmaceuticals Co Ltd, a global pharmaceutical company focusing on scientific and technological innovation, announced on March 25 that it has entered into an exclusive license ...

The 2023 decision to upend affirmative action, coupled with ongoing federal funding cuts, may threaten representation of Black leaders in the pharma industry.

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure – black-painted ... another laboratory and/or pharmaceutical manufacturing ...

Trump touted the stock market’s turnaround Wednesday afternoon following his 90-day pause on so-called retaliatory tariffs above 10%. “The geniuses of the world, They get it. Our country’s ...

Leaders at Merck & Co. Inc. are facing a new derivative shareholder lawsuit over allegations that they made misleading comments about traction in China over its HPV vaccine. “Merck has suffered and ...